What is MS Phase 2 Study ONO-4641?

Category: Others

false

See also: Clinical Trial

NCT01081782 is a a double-blind, placebo-controlled study of the safety and efficacy of ONO-4641 in patients with relapsing-remitting multiple sclerosis. Other study names is ONO-4641POU006.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 0
Mild 0
None 1

Commonly reported side effects and conditions associated with MS Phase 2 Study ONO-4641

Side effect Patients

Why patients stopped taking MS Phase 2 Study ONO-4641

Multiple reasons could be selected

Reason Patients
Did not seem to work 1
Doctor's advice 1
See 1 patient who's stopped using MS Phase 2 Study ONO-4641

Duration

Stopped using MS Phase 2 Study ONO-4641

Duration Patients
6 months - 1 year 1
Adherence
Adherence Evaluations
Always 1
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 0
Not at all hard to take 1
Last updated:
There are no evaluations for MS Phase 2 Study ONO-4641.